Keep our stock updates top of mind

BECTON DICKINSON & CO. $234 is a buy. The medical device maker (New York symbol BDX; Manufacturing sector; Shares outstanding: 283.9 million; Market cap: $66.4 billion; Dividend yield: 1.6%; Takeover Target Rating: Medium; www.bd.com) has agreed to acquire the Critical Care product group of Edwards Lifesciences Corp. (New York… Read More

Alcon gains with long-term trends

Swiss pharmaceutical giant Novartis spun off Alcon in 2019. As we’ve said many times before, spinoffs are the closest thing you can find to a sure thing, regardless of the market’s rise and fall.
The stock is already up over 42% since we first recommended it… Read More

Keep our stock updates top of mind

JOHNSON & JOHNSON $153 is a spinoff buy. The company (New York symbol JNJ; Manufacturing sector; Shares outstanding: 2.4 billion; Market cap: $367.2 billion; Dividend yield: 3.3%; Takeover Target Rating: Medium; www.jnj.com) is an American multinational corporation that develops medical devices and pharmaceuticals.
In May 2023, the company sold shares… Read More